11/21
08:00 am
crbp
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
Medium
Report
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
11/12
08:00 am
crbp
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Low
Report
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/9
10:11 am
crbp
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate [Yahoo! Finance]
11/7
07:00 am
crbp
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
Low
Report
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
11/4
10:47 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
11/4
07:00 am
crbp
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
Medium
Report
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
10/29
08:00 am
crbp
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
Low
Report
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
10/16
08:00 am
crbp
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
Low
Report
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
9/26
08:00 am
crbp
Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit
Low
Report
Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit
9/23
08:17 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
9/20
02:17 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at B. Riley from $85.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at B. Riley from $85.00 to $40.00. They now have a "buy" rating on the stock.
9/20
12:19 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Wedbush from $85.00 to $51.00. They now have an "outperform" rating on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Wedbush from $85.00 to $51.00. They now have an "outperform" rating on the stock.
9/20
12:19 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Mizuho. They now have a $74.00 price target on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Mizuho. They now have a $74.00 price target on the stock.
9/20
11:09 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $82.00 price target on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $82.00 price target on the stock.
9/5
08:00 am
crbp
Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference
Medium
Report
Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference
9/4
07:43 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right Now [Yahoo! Finance]
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right Now [Yahoo! Finance]
9/4
07:40 pm
crbp
California settles lawsuit with Sacramento suburb over affordable housing project [Yahoo! Finance Canada]
Medium
Report
California settles lawsuit with Sacramento suburb over affordable housing project [Yahoo! Finance Canada]
8/28
09:18 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $82.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $82.00 price target on the stock.
8/27
08:13 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer's Top Stock Picks For the Next 12 Months [Yahoo! Finance]
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer's Top Stock Picks For the Next 12 Months [Yahoo! Finance]